Cardinal Health, Inc. $CAH Shares Sold by CWA Asset Management Group LLC

CWA Asset Management Group LLC lessened its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 5.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 81,621 shares of the company’s stock after selling 4,325 shares during the quarter. CWA Asset Management Group LLC’s holdings in Cardinal Health were worth $16,773,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of CAH. SJS Investment Consulting Inc. raised its holdings in Cardinal Health by 1,363.6% during the third quarter. SJS Investment Consulting Inc. now owns 161 shares of the company’s stock worth $25,000 after purchasing an additional 150 shares during the last quarter. Aventura Private Wealth LLC acquired a new stake in Cardinal Health in the fourth quarter valued at $25,000. Jones Financial Companies Lllp grew its holdings in Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares during the last quarter. JPL Wealth Management LLC purchased a new position in shares of Cardinal Health in the third quarter valued at $31,000. Finally, Turning Point Benefit Group Inc. acquired a new position in shares of Cardinal Health during the 3rd quarter worth $31,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Price Performance

NYSE:CAH opened at $207.91 on Friday. The firm has a 50 day simple moving average of $217.62 and a 200-day simple moving average of $194.11. The firm has a market cap of $48.93 billion, a PE ratio of 29.92, a P/E/G ratio of 1.36 and a beta of 0.65. Cardinal Health, Inc. has a 1-year low of $120.72 and a 1-year high of $233.60.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, February 5th. The company reported $2.63 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.31 by $0.32. The firm had revenue of $65.63 billion for the quarter, compared to analyst estimates of $64.88 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 92.50%. Cardinal Health’s revenue was up 18.8% compared to the same quarter last year. During the same quarter last year, the business earned $1.93 earnings per share. As a group, sell-side analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 15th. Investors of record on Wednesday, April 1st will be paid a $0.5107 dividend. This represents a $2.04 annualized dividend and a yield of 1.0%. The ex-dividend date is Wednesday, April 1st. Cardinal Health’s dividend payout ratio is presently 29.35%.

Analyst Upgrades and Downgrades

CAH has been the topic of a number of research reports. Wells Fargo & Company increased their price objective on shares of Cardinal Health from $237.00 to $256.00 and gave the company an “overweight” rating in a research note on Tuesday, February 10th. TD Cowen upped their price target on shares of Cardinal Health from $233.00 to $251.00 and gave the company a “buy” rating in a report on Wednesday, February 11th. Zacks Research upgraded shares of Cardinal Health from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 12th. Morgan Stanley set a $255.00 price objective on shares of Cardinal Health in a research note on Friday, February 6th. Finally, Barclays lifted their price objective on Cardinal Health from $243.00 to $258.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 24th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, Cardinal Health has an average rating of “Moderate Buy” and a consensus price target of $245.67.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.